Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria

Abstract

Background

Biomarkers useful for the evaluation and management of patients with chronic spontaneous urticaria (CSU) are not currently available.

Objective

A review of various clinical and laboratory markers that have been studied to assess their value for determining the severity or predicting the evolution of disease in adult patients with CSU.

Methods

A search of the medical literature on Pubmed and MEDLINE including the terms urticaria, chronic urticaria, chronic idiopathic urticaria, chronic spontaneous urticaria, severity, prognosis, and treatment.

Results

Based on our review of the literature, among the clinical markers studied, higher age at onset, being female, long disease duration, and aspirin/NSAID hypersensitivity may be linked to both, severe CSU and a long time to spontaneous remission. In addition, a positive autologous serum skin test (ASST) may be associated with severe CSU, and comorbidity of inducible urticaria and concomitant recurrent angioedema may be linked to longer CSU duration. Potential biomarkers of CSU severity and/or duration include basophil numbers and susceptibility to activation, inflammatory markers, markers of activation of the extrinsic coagulation pathway, immunoglobulin E, and vitamin D.

Conclusion

Although the described markers are promising, further studies on representative and well characterized patient populations are needed to determine the value of these clinical and biological markers for predicting the severity and course of disease in patients with CSU.

This article is protected by copyright. All rights reserved.

http://ift.tt/2m3JSSb